GEHC
GE HealthCare Technologies Inc.
Mentions (24Hr)
0.00% Today
Reddit Posts
Pre-Market Gainers and Losers for Today (July 29, 2026) 📈 📉
How do y’all feel about General Electric (GE)?
GE HealthCare stock falls despite Q1 beat (NASDAQ:GEHC)
GE HealthCare and Sinopharm to form joint venture in China (NASDAQ:GEHC)
Mentions
People have seen the growth of the Mag7 in the past decade and thus conclude that buying a company and never looking at it again is the best strategy. People still do that with the megacaps, not realizing that the past growth can't possibly be replicated given the sheer size of the corporations. In regards to the "buy and hold for 20 years" strategy seen so often here - if you adopted that strategy 20 years ago to now with some of the biggest / most popular corporation of the time you missed out enormously if you didn't actively manage your positions and should have just gone with the S&P. Citigroup is 70% lower than it was 20 years ago. Pfizer was the largest pharma company in the world 20 years ago but if you held it through to now you made exactly zero percent return. Walgreens was a blue chip that lost 70% and then went private forcing you to sell shares. GE, even if you count the GEHC and GEV spinoff, is up 2x in 20 years. Exxon? 2x. Cisco? 3.5x. If you took the top 10 companies by market cap 20 years ago and bought and held them to now, the index would be badly beating you and two of your positions would have been completely wiped out (Citi / AIG). In fact, of those companies only MSFT significantly best the index and WMT ran par with the index.
Not for everyone, but his is my process My investing philosophy for the upside (makes sure you have a price target based on your DD and actively monitor), I typically sell 1/3 or 1/4 if it grows 25-50% (no harm in taking profits). If it doubles, I sell half and let the remainder ride as I view these as "free" shares from my original investment dollars. They become part of "hold and forget" portfolio that I only tap if I need the money for a big purchase (car, home remodel, vacation...). Today, my "hold and forget" include HON (\~$30 cost basis), META ($19), AMD ($2), GE ($6 pre reverse ship), LLY ($60), BRK.B ($101), INTC ($19). The account is also set to re-invest dividends. Because I held I also have shares of HONA, GEV, GEHC, SOLS that are also part of my hold and forget.
Easy - HON, HONA, SOLS, GE, GEHC. GEV, ZTS
fuck it, I’ll buy some GEHC why not
Never thought the GEHC I bought as a defense play would moon like this.
"However, if the mobility division was economically attractive, " Tons of great companies have come from spin-offs where the value isn't being realized within the larger company. CEG is an example of a very successful spin-off. Look at how well GE's break up has gone for 2 out of the 3 names (and I still think GEHC is interesting.) "do it now or after the carve out?" If you think the stock broadly is very attractive now, I'd say no vs SPGI ex-mobility later that is possibly higher/less attractive.
There have already been hyped up names around AI drug discovery like RXRX; a name that I said a while ago that I thought was a short and wish I would have. "$CRSP, $NTLA, and $BEAM" All Ark-y names that have generally not traded that well over the last 5 years or so. I like investing in biotech, but don't own any of these. " $ILMN is building the infrastructure behind the industry," I'd rather own TMO than ILMN but life science has continued to be awful post-covid given overcapacity and other issues. I think AI would be particularly useful in terms of things like medical imaging - not long those names but that hasn't worked out well yet either - GEHC and the rest of medtech have had a lousy year. I'd like healthcare to be a more meaningful beneficiary of AI but I have yet to see the kind of meaningful progress I'd like. Most of it has been hype with little to show for it (rxrx)
Diabetes care, healthcare technology. This sector is rather beat down lately, but the multiples are solid and should weather a down-turn nicely, plus good growth potential. ABT, DXCM, MDT, GEHC, NVO. Maybe BAX or possibly even PODD.
GEHC is interesting. GE CEO Culp buying GEHC yesterday.
One day CRSP will come through, hopefully AI can help accelerate their research. But I’m with you about Healthcare, such a boring slow growth sector. I’d probably do a 60%GEV/30%GE/10% GEHV split or something like that. Definitely grabbing GE before GEHC though!
I dont feel GEHC would be a bad play right now. I've been eyeing it a while..Just a little leary of the Healthcare space. And every other space right now except space.
How about GEHC though?? I have GEV and wondering if I should just hold all of them
Yesterday you went Puts on CDW and GEHC which are both up this morning. Inverse this guy
Closed Today: Took profits on PYPL puts, and ATI • BALL calls Opened Today: - Calls: FLEX • NVO • SIMO • VVV - Puts: CDW • GEHC • SWKS *Disclaimer: This is not investment advice despite the fact I look good in a vest.*
Got a bunch of GEHC in the spin-off and it’s been pretty disappointing. Not sure this will be the game changer you say but any positive news is welcome I guess.
They split the business into GE (GE Aerospace), GEV (GE Vernova), and GEHC (GE Healthcare).
Thank you. I've been adding a lot this year into Google, GEV, CEG and a little more Joby. Sold JNJ and GEHC. PEP has been crap but I'm just collecting the dividend. I haven't added too much to MSFT besides a few shares in April. I'd like to see MSFT go closer to 450$.
GE also still exists. If you had bought GE when it was dominant in the early 1900s then you'd be fine. By the time it went old you'd be old, dead, spent it all, and/or gave it to your kids to worry about. GE which split into GEHC, GE, and GEV are still a better investment than INTC.
HON spun off Solstice Advanced Materials, SOLS. HON is trying to go the way of GE, GE spunoff GEHC and GEV. Sort of ironic, Jack Welch and GE made a play for HON in 2000, 2001.
I trimmed a little at 2.6 when i saw the market turning to secure some profits and get rid of my leveraged portion of the position. still holding the rest. I'll trim off the rest at $2 if it fails for less profits (in at 1.5 this morning) but i largely base my trims on the price action. Hoping for $3.5-$4 but largely dependent on buying volume. I was looking at the market just now for EKG demand and got this so far: # Launch Timeline & Market Revenue Heartbeam is currently a **pre-revenue company** focused on product rollout. Specific revenue estimates from the company are **not publically stated** at this time, but the plan is: * **Launch Target:** A **limited U.S. commercial launch** is planned for **Q1 2026** (early 2026). * **Initial Focus:** The launch will target select **concierge and preventive cardiology groups** who have already shown interest, establishing a high-value beachhead. * **Market Context:** They are entering a huge, growing market: * Global Mobile ECG Devices Market: **$4.53 Billion (2025)**, expected to reach **$8.89 Billion by 2032**. * Analyst sentiment is generally positive ("Buy" ratings), reflecting optimism about their disruptive technology in this multi-billion dollar space. # Heartbeam's Competitive Landscape Heartbeam's main advantage is the **12-lead synthesis**. This places them uniquely between simple consumer devices and complex hospital equipment. # 1. Direct At-Home Mobile ECG Competitors These devices are the most direct threat in terms of convenience and consumer adoption, but they lack the full 12-lead capability. * **AliveCor (KardiaMobile, 6L):** The market leader in personal ECG, offering up to **6-lead** recordings, but not a full 12-lead synthesis. * **iRhythm Technologies (Zio Patch):** Dominant in the **extended-wear/Holter monitor** market segment. * **Consumer Wearables (Apple Watch, Samsung):** Offer single-lead (I) rhythm checks, but minimal clinical diagnostic value compared to 12-lead. # 2. Traditional Medical Device Giants These giants own the existing clinical EKG market and could eventually develop competing technology. * **GE HealthCare (GEHC)** * **Koninklijke Philips N.V. (Philips Healthcare)** * **Abbott Laboratories** * **Medtronic plc** With a current market cap of 88m I think this stock will have a lot of room for growth, plan to hold 200 shares for the longer term
I can't tell if you are serious or not since you used the ... I mean the GE spin off have done extremely well lol. As an investor, it's a great idea, since it's easier to understand smaller businesses. I mean GEV spun off on April 2, 2024. It's only up 325% since that spin off. GE it's self is up like 100% since then. GEHC is the only one that hasn't done as well. However, there been a handful of other successful spin offs of recent. CARR, NXT, ECG are a few others than done well after spinning off.
Falling knife. My advice. Take your losses and diversify. CELH, CGTX, UPS, B, GEHC, QUBT/IONQ, MBOT.
taking a risk on these beaten down babies SOFI TMUS FI GEHC they’ve got some recent hedge fund action
"Because health insurance isn't going anywhere. " But someone could have said that (and a lot of people on here did) with UNH $50 higher. Health insurance cos probably aren't going anywhere but it's an intentionally very complex industry and I look at the intricacies of health insurance cos and I go "I know what I don't know and I don't know this well enough to have an opinion on it." Someone replied to me in another thread months ago about UNH and basically said that they've been a doctor for many years and what's the one sector they didn't have an investment in? Health insurance. "GEHC" I've often thought even before tariffs that there's a fair amount to like about GEHC when considering the future and yet the stock has never really acted that well (or if it has, not for that long) and earnings have been often ... okay. I've owned it a couple of times but keeps winding up being a trade rather than something that sticks. There are things in healthcare that are working, but a lot isn't. I don't know - imo, I've had a good year and therefore, I've been looking to trim a little of what's working and look to gradually add what hasn't. If I allocate a *reasonable* amount to those situations, I'm happy to wait. But anyone expecting things to change tomorrow though might continue to be disappointed.
Somebody's trying to get ahead of the GEHC earnings tomorrow.
I have a position in GEHC. was thinking about entering a general healthcare ETF and holding waiting for a sector rotation Not sure wha move I’ll make yet. I’m fully invested in QXO.
GEHC and BMY aren't too down i would say, would u still wait for the bill to be passed and then see the results and then get in or would you say right now is the correct time?
I like GEHC, as mentioned. BMY will probably rise from the dead too. CRSP moving lately too. Once the sector rotates into healthcare, most of the strong names will rise.
Nah. They want to suck the wealth from the boomers as much as possible before death. Time to buy healthcare stocks. GEHC looking nice, along with other pharma stocks. Healthcare will rebound huge.
Reverse splits are not only due to financial perils, but GE did a 1:6 reverse split to decrease the number of outstanding shares and then split into three companies (GE, GEV, GEHC). I have every nice gains because I always thought the parts were worth more than whole.
GE was a huge fucking profit if you held it. I averaged 87/share buying, sold at 200, it's at 250. And that doesn't count the shares of GEV and GEHC I got, which paid quite well.
Best dips I bought were BA, CEG, GEV, GEHC and AMZN
EME or TTD if you want to be speculative. Vertex if you’re feeling more conservative. My next buys are some EME and some more GEHC
$MAR puts --> $AMD puts --> $BROS calls --> $TTD calls Track record of success: right on QCOM/GEHC last week, very fucking wrong on Duolingo 
Sold my $GEHC calls for 60% gain and then they immediately crashed 💀
Hopefully GEHC stays green so I can sell my calls at open 😭
Monday: $TER 70p 5/16 Tuesday: $GEHC 72c 5/16 Wednesday: maybe QCOM puts depending on chart Thoughts?
I see why GEHC is being abnormally hit. China apparently restricting purchase of MRI machines along with their tariffs.
Normally GEHC would be where you flee for safety as it’s health, Medtech, software. Down 30% since inauguration.
Also there was a stock split - when I initially invest it was GE, than it turned into GE/GEV/GEHC
Hi Reddit, this is my current portfolio - open to any suggestions! Currently sitting at $64,806.02 * **GE**: 11.21% * **GEHC**: 3.59% * **GEV**: 2.69% * **QQQ**: 2.47% * **SCHD**: 53.59% * **XLK**: 19.51% * **VOO**: 6.95% The rest is cash - $4008.00
# Industrials * **Winners:** **BA** (+4.95%) had a strong week, driven by renewed demand optimism. * **Losers:** **DE** (-4.43%) and **GEHC** (-5.32%) underperformed. * **Trend:** Results were mixed but leaned negative, reflecting ongoing supply chain and demand pressures.
https://finance.yahoo.com/news/hospitals-not-going-to-manage-hundreds-of-partnerships-in-digital-health-ceo-says-154612559.html Great weekend sentiement when hospitals as in plural will have fewer partnerships, but deeper relationships with only PLTR and GEHC mentioned in the article.
"What are your thoughts?" It would appear that we're somewhere between sort of "phase 1" (spending on data centers and other capex) and "phase 2" (if ai is now cheaper, who benefits - and that's not necessarily tech.) It feels like anyone with a lot of data benefits (Meta; in healthcare I think IQV's data is underappreciated.) I think names that generate/deal with a lot of imaging will benefit from reasonably priced AI - GEHC, for example - or something like MSI (https://www.motorolasolutions.com/en_xl/video-security-access-control/video-analysis-artificial-intelligence.html) "Edge computing" names benefit in tech - look at Cloudflare lately. Software names have done well lately and there will be some winners but I still have a difficult time not seeing how some software names (ADBE) aren't potentially facing lasting challenges given the current state of the business at least. This is a very basic take written early in the morning, but basically: I don't think phase 1 is entirely over but if you are a company involved in building data centers and the growth in that seemed to stretch beyond the horizon for years, now we're looking at a situation where you still might have contacts *to* the horizon but the market just re-rated the *beyond* the horizon much (and in some cases much much) lower.
You’re quite right that despite being up like 80% (?) this year, GE has done effectively nothing over the decades long range. Be careful about analyzing just GE stock though as they’ve done spinoffs. I got lots of GEHC and GEV shares for free as they’ve been spun off.
Definitely Ge aerospace, so undervalued, and I think GEV is gonna be huge with this new administration, plus I’ve been looking at GEHC too. And definitely Amazon.
The best money to be made is when everyone else is scared. This is like when GE was $8 and everyone said it was going bankrupt. Then it reverse split 8/1 and started to rocket. 100% gain then they split the stock into two different companies and you got both stocks for each share, it was like a free stock. Now GE is $160+ and GEHC is $80+. It happens fairly often where FUD overwhelms what is a solid company, which made some mistakes, and are getting punished for it. Look at the banks in 2023, I bought WAL at $19 and they were going bankrupt too. Except they didn’t and now it’s worth $89 a share. SMCI might suffer some more but the underlying business is needed by other companies and is a profitable business. So you can bash the stock but the company will still be there and will eventually come back. It could obviously be awhile. Being removed from the Nasdaq is not going to end the stock either it’s not that detrimental. Sending Me Cash In 2025
really enjoying this GEHC dip i like moats and don’t like overpumped stocks sorry gentlemen
Gordon Gekko vibes, welcome in the 1980's / 1990's, Greed is good, where is my blood pressure cuff! Long\* in GEHC / BAX
Anyone bullish on Honeywell (NYSE: HON), with Elliot Management buying a massive stake to break the company apart, similar to how GE, GEV, GEHC came about?
One important point - Trump can make a [Recess Appointment](https://constitution.congress.gov/browse/essay/artII-S2-C3-1/ALDE_00001144/) \- good for two years without Senate approval. Secondly, I am expecting some significant departures at the FDA that will stymie drug and device approval. On PFE I always viewed PFE as an acquirer of technology, not innovative. Some of the acquisition were integrated well, other poorly. I suspect their Seagen acquisition is underperforming (it still may be too early to tell) and they are also playing catch-up on the GLP craze. With the latest news, I expect a mass exit of personnel from some of FDA units that will slow the approval processes and other than vaccines, I see any new GLP-1 approvals will have an uphill battle. I personally am staying away until I see a more positive trend / news. If I was going to invest, I would look at companies with a "moat' in the medical device area or so big they have few competitors, like RMD or GEHC.
With uncertainty of the FDA, I am staying await from any new drug approvals companies. I have long-term positions in LLY and MRK. At this time, the medical device segment maybe better - I have a position in GEHC. I have also been looking at RMD but waiting to see if it pulls back closer to $200.
Got a good feeling about GEHC
Not a spinoff, more so a split of resources. GE was tired of being a slow conglomerate. Easiest way to fix that is to become more lean. Thus GE (aero), GEHC, and GEV were born. Fwiw idt it's too late to buy in. I see a lot of potential in GEV and their leadership going forward.
You talk about AI and the potential but are piling into all the names everyone else owns. Aside from NVDA (arguably already the most popular/widely followed stock on the planet), you're focused on the spenders and not the beneficiaries of the spending. VRT? STRL? Both up more than any non-NVDA mega cap tech names. PWR/EME? If you think that AI will benefit industries, why not something like GEHC? If you think that AI will have that kind of a benefit in medical diagnosis, why not the largest (I think? If not, certainly top 3) imaging company? You make a mall comparison and talk about the retailers but have this sort of "Field of Dreams"-ish view of "if you build it they will come." What if they don't? If they don't the beneficiaries of the spending make their money anyways. And I'm not saying that you're wrong, but for all the hype over AI in this post, the core is that it's going to transform industries in "ways we can't imagine yet", which feels Cathie Wood-ish in that it doesn't entertain the possibility that the hot growth theme doesn't go 100% as hoped. Yes maybe it will do a lot of great things but "it's going to do everything great" feels "all the disruptive growth themes are going to the moon" from 2020/21. It's just not a balanced discussion and while the potential is significant there's certainly risks. "Anyone else rethinking their portfolio with AI at the center?" Nope. I have tech and non tech exposure to AI but don't really see the need at this point to dial it up (or down.)
GEV is up 127% though GEHC is also beating the market since IPO
Yup, bought in early 2020 around $4, jumped to $12, reverse split to ~$110, dropped to ~$60, and just sold GE around $185. I dumped GEHC and GEV about a month ago.
More than that even. I'm showing 270% on my GE lots alone, not including the GEHC and GEV spinoff shares. Will it continue going up? Unclear. Morningstar rates it as the fairly valued for whatever that's worth but a P/E of 40 is worrisome for a capital intensive stock.
I was very successful with GE. It had a clear and defined trading range and was easy money for quite a while. In my opinion the stock of GEHC should be more successful than what we've seen. Long term I think it's fine
Healthcare tech is highly competitive and GEHC is the best in some areas while their competitors beat them in others. Philips, Draeger, Mindray, Siemens are all examples of direct competitors in various modalities. GEHC has a more diverse offering than most of their competitors but they aren't super dominant in many of these modalities. I think they probably have the largest service offering, and probably the best MRI and PET rooms and their big iron in general is cutting edge outside of X Ray which is an end point modality anyway. But they are competitive rather than dominant overall, as someone working in the specific field GEHC operates. I don't think anyone is getting rich on a moonshot GEHC stock but it's probably not a terrible long holding.
There have been stocks splits and spin-offs (GEHC = GE Healthcare, GEV + GE Vernon) - plus if she had dividends re-invested you may have more shares. It is tough to tell. The transfer agent will give you a better idea.
I worked with GEHC in that time frame and practically nobody took the ESPP offer... which I kinda regret now. Would've been a decent bonus.
they did a reverse split 10:1 I believe... I worked at GE in 2000 when the stock was $90 .. saw it go down to below ten.. the reverse split and diversification.. into GEHC, GEV, and GE..
GE is the perfect example and has the same vibe as Intc. gE bottomed at $40 then started climbing, split into multiple stocks ( GE + GEHC) which original shareholders got both of, and GE is now at $160+. I don't like either stock but I've held both of them and Intc just feels a lot like GE, but I could be wrong..
Bad move. I bought at $30 because I thought it was the bottom and I regret it. I think intel will drop further below. This reminds me of when I bought GE in 2018 after they dropped like a rock. The rock kept dropping! I’m still in the red on GEHC after the companies split.
I personally stay away from small single device companies. I prefer GEHC.
Well, you have plenty of growth through tech exposure, you have a solid basis of market wide ETF. So if I were you, and I wanted a long-term position in individual names, absent short-term concerns, which may outperform the market: Financial (JPM) Industrial (GE) Healthcare (GEHC, LLY)
Right, they now run as three different companies (GE,GEHC,GEV). Another big driver is post COVID turbine orders, for which they have very little competition I've been reasonably happy with BRK but if you drag out the chart it doesn't behave that much different than an index. It just rounds out the edges a bit
I remember hearing on Bloomberg surveillance 3-4 times over a period of like 18/24 months about their debt reduction, restructuring, and prepping for spinoffs. Even the commentators would ask the analysts questions like: “great they’ve done all this work, why hasn’t the stock moved?” Knew they do production of a lot of wind turbine stuff and saw the writing on the wall for ‘green new deal’ esque legislation and just energy demand in general. To the point of GP the stock appeared to be flat or down on most longer term time horizons. Went in for 400 shares in Jan 2021 total buy about $4445 (pre 8:1 reverse split), up to over $11300 now including $GE ticker returns, some minor DRIP, and the value of the two spinoffs $GEHC and $GEV (still holding all 3 for now). Can’t lie I got pretty lucky on the exact timing of my buys in retrospect but it seemed like a company with improved prospects and some catalysts for return that just hadn’t taken off yet and then boom.
Hey there, I’m 20 and from the US. I have 2 shares in NVDA, GEHC, and Bristol Meyers, I’m looking to invest 600 dollars in some companies including TSM, META, the ones I’ve already invested in, or others. I want to create a diverse portfolio that isn’t super high risk. I don’t need it to be 100% safe, but I’d like really good signs as a long term investment. Does anyone have any advice based on this info? Thank you!
Why? Because AI make money Cure don’t make money Treatment make money Treatment make lifelong customers But seriously this is what AI should be doing. It would be so fucking powerful finding those patterns we can’t calculate at a speed AI can. I’m hoping some companies are trying, I have a position in GEHC with some hopium.
It seems to have worked pretty well for General Electric with GE, GEV and GEHC. All of which have had nice gains in their short existence. IBM with KD not so much but I viewed that as dumping a low profit margin business. Kellogg splitting Kellanova seems to have marginal success on the low profit marginal cereal business vs. the better profit margin snack food on the other side of which has done well. I think investors need to look at which side(s) gets the higher profit margin products vs. homogeneous, low-profit products.
If the shares are registered in GE DRIP (dividend reinvestment program) - you dividends have been re-invested over the years and you have more share now. GE over the last 2+ have spun off it medical (GEHC) and power (GEV) division to which you got shares in the spin-off companies. I suspect the $100 was for partial share not convert. I recommend you contact [GE Shareholder Services](https://www.ge.com/investor-relations/shareholder-services) to find out the number of shares you have in each entity and their value and then make decisions.
I full ported weekly GEHC calls based on nothing but the fact that it went down a lot today and IV on calls was cheap
About to full port into GEHC weekly C’s, a fellow regard plz talk me out of it
GEHC’s done pretty damn good for itself.
Can someone help me out on understanding a stock split (I don't own the company, this is for a hypothetical contest I am simulating) I want what I am saying to be accurate in terms of [how Yahoo Finance states price histories/splits](https://i.imgur.com/K9tumRE.png). Suppose I 'owned' 166 shares of GE starting Jan 2022. Then it spun off in January 2023 GEHC (healthcare segment). Shareholders got 1 share of GEHC for every 3 of GE held on record a few days earlier. So I get 166 / 3 = 55.3 shares of GEHC. Yahoo Finance records a 1281:1000 split for GE. So using its split-adjusted prices, I record owning 166 * 1281 / 1000 shares from January 2022 onward, or 212.65 shares. (This is why there is no big jump in share prices around the split dates in Yahoo Finance). I'm assuming I should *not* have computed 212.65/3 = 70 shares of GEHC, and using 166 / 3 is correct. Now comes April 2024. GE spins off its energy business GEV. Now 1 share of GEV for every 4 of GE held on record a few days earlier. But I don't own 166 shares anymore, I own 212.65 shares (at post-split prices). Therefore I am awarded 212.65 / 4 = 53.2 shares of GEV. (Right?) Yahoo Finance records a 1253:1000 split, so 212.65 pre-split shares = 266.5 post-split shares. **Summary:** My original 166 shares of GE is equivalent to the following post-split adjusted history: - January 2022 through January 2023: I have 266.5 (= 166 * 1281/1000 * 1253 / 1000) shares of GE. - January 2023 through April 2024: I have 266.5 shares of GE and 55.3 (= 166 / 3) shares of GEHC - April 2024 onward: I have 266.5 shares of GE, 55.3 shares of GEHC, and 53.2 (= 166 * 1281 / 1000 * 0.333) shares of GEV. Is that correct?
I’ve been in a while. With the spin offs of GEHC and GEV today I am looking at 400% profit. Got a bit to run yet too IMO.
I am guessing the first one GE1 is after GEHC spin-off and GE2 is after this GEV spin-off?
It may be because the deliverable was changed. The deliverable per contract effective today is now: 1) 100 GE Aerospace (GE) Common Shares 2) 25 (New) GE Vernova Inc. (GEV) Common Shares 3) 33 GE HealthCare Technologies Inc. (GEHC) Common Shares 4) $19.62 Cash Source: [https://infomemo.theocc.com/infomemos?number=54399](https://infomemo.theocc.com/infomemos?number=54399)
Yup, scared the shit out of me when GE dropped off 20% earlier but those are now made up for as GEV. Have about 800 shares between GE, GEHC, and GEV now.
I’m still new to this whole Reddit thing. But can’t DM you? Anyways I’ll post here. $GEHC. Anything you know about them? Earnings coming up April 23
A couple years ago GE was in a rough state but GE is up 88% percent YoY, pays a dividend quarterly and last year spun off GE Health Care, existing shareholders received a 1 share of GEHC for each 3 shares of GE, GEHC now trades at $90 so essentially a $30 dividend. And next month they're doing a 1:4 spinoff of their aviation division.
As it worked for my GEHC, my cost basis is based on the price(s) i purchased my GE shares for. I have several different cost basis numbers on GEHC. Not sure if this helps?
Is anyone trimming their GE position before the 19th, in hopes to buy back/buy in GE and GEV at a later date? OR adding to their GE position before the 19th? OR just holding their current GE position? I am just adding a couple shares to get exact 4-1 and then likely adding to alll three on pullbacks. I did this on GEHC spin off and have done well. Im typically hesitant adding any at or close to 52 week highs. I May regret not adding more GE before spin off…lol :/
I did very well with GEHC spin off. I will add a another share or to to get the exact 4-1 of GEV. I am bullish long on all 3. GE was a bet that has paid off well and I hope all 3 will outperform market over next several years
When GE first split Into GE and GEHC, both went up. That dosnt mean the same thing will happen again.
I currently hold LEAPS on NNOX and RXRX. I have been accumulating stock in GEHC for long-term B & H. EXAI is a long shot play I am watching. Its recent breakout could finally be a turn in its long down cycle.
> Except that when gehc split both stocks rose considerably. I'm hopeful both will do the same again with vernova But these were probably not because of the splits, and other underlying reasons. Did you research why the splits caused their stocks to rise? What value was GEHC before? The only times I've seen stock splits cause a rise in market cap is when a company whose stock costs 500 - 1000 dollars splits and makes it self more affordable to investors who don't have options to buy partial stock.
Thanks, I appreciate your take on it. I agree, I’m much more excited by the aerospace. Out of curiosity, how do you feel about their Healthcare GEHC? It doesn’t seem to be doing well.
what is everyone buying? I can't find any stock that will grow largely this year. the only thing I could find was GEHC
Love GE. GEHC calls have been nice, too.
I was going to be snarky and say, ‘I haven’t been this excited since General Electric spun off GEHC.’ But honestly GEHC hasn’t done badly. Maybe 3MHC isn’t such a bad idea.
My own 5 year investment strategy is on AI picks & shovels and applications. I selected two investments in companies with products and services that will have impact in the broadest worldwide applications. I chose these 2 from Telecom and Healthcare, and hold both in long positions in my portfolio. My Telecom choice is NOK due to their deep and longstanding inside track with 5G and coming 6G IP and solutions that will be needed to serve the explosive demand for secure, high bandwidth, and low latency network performance. I think telecom is the most essential of industries and sectors for this next wave of demand from all things AI, IoT, autonomous vehicles, healthcare, media, and so on. In Healthcare I like GEHC which was the healthcare business spun out of GE last year. Their emphasis and industry lead on AI and innovation to address and solve medical issues and provide advanced care will only be in greater demand as infrastructure and technology are used more frequently to provide better quality of care and lower medical costs. Both are very profitable and generate strong cash flow, while remaining technology leaders in their respective industries.
CVS will go up with GEHC 🙏